A phase 2 trial of apatinib combined with intensity modulated radiation therapy for patients with unresectable hepatocelluar carcinoma.

Shaobo Ke,Hu Qiu,Jin Peng,Gaoke Cai,Yutian Zhangcai,Hao Cheng,Yuxin Cai,Lingling Xia,Xixi Luo,Yong Wu,Yi Gong,Jing Wang,Wei Shi,Jiamei Chen,Wensi Zhao,Shasha Ruan,Yongshun Chen

A phase 2 trial of apatinib combined with intensity modulated radiation therapy for patients with unresectable hepatocelluar carcinoma.

2021

Shaobo Ke
Hu Qiu
Jin Peng
Gaoke Cai
Yutian Zhangcai
Hao Cheng
Yuxin Cai
Lingling Xia
Xixi Luo
Yong Wu
Yi Gong
Jing Wang
Wei Shi
Jiamei Chen
Wensi Zhao
Shasha Ruan
Yongshun Chen

e16136Background: To estimate the clinical outcomes and safety for patients with unresectable advanced hepatocelluar carcinoma (HCC) treated with apatinib in combination with intensity modulated ra...

Keywords:

Intensity (physics)
Intensity-modulated radiation therapy
Nuclear medicine
Phase (waves)
Apatinib
hepatocelluar carcinoma
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations